BioWorld

Aug. 20, 2002

Saegis Nearing End Of Phase II While Still Using Series A Cash

As the baby boomers age, many will face problems with memory they used to associate with their parents and grandparents. (BioWorld Today) Read More

Tragen Seeks Funding, Partners For Phase II Cancer Compound

Anti-Angiogenic Drug, VEGF-Trap By Name, Most Potent Ever Seen,' Scores In Preclinical Mouse Tests

Shares Of OSI, ImClone Take Hit On AstraZeneca Results

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Jan 12, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 12, 2026.

3D rendering of antibody drug conjugated with cytotoxic payload

ADCs’ breakout 2025 and their still-unfinished potential

BioWorld Science

Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...

LINC01116 has prognostic value in lung cancer, study shows

BioWorld Science

Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...

ADCs’ breakout 2025 and their still-unfinished potential

BioWorld

Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...